BIOTECHNOLOGY and PHARMA NEWS 2010

Community

Advertising Opportunities

Biotechnology Europe Programs

Resources

Biotechnology Europe Community

Feedback

Contact

Biotechnology Europe Advantages

Advertising Opportunities on Biotechnology Europe

Sponsorship Opportunities on Biotechnology Europe

Post a Job on Biotechnology Europe

Post a Company Profile on Biotechnology Europe

Post a News on Biotechnology Europe

Post an Event on Biotechnology Europe

Post a Product on Biotechnology Europe

Post a Publication on Biotechnology Europe

Post a Technology on Biotechnology Europe

Post a Resume on Biotechnology Europe

BIOTECHNOLOGY EUROPE NEWS

post your news I subscribe newsletter I contact us

30.01.2010 UBI Announces Launch of One Touch “Verio” in Netherlands by LifeScan, Inc

27.01.2010 Oxford BioMedica and Bavarian Nordic Announce Settlement of MVA-BN® Litigation and Cross License of Patents

27.01.2010 Oxford BioMedica and ALS Therapy Development Institute Extend Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis

26.01.2010 Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma

26.01.2010 MorphoSys Licenses HuCAL PLATINUM® Antibody Library to Shionogi in Research Partnership

25.01.2010 Announcing the New deCODE

22.01.2010 Oxford BioMedica Secures Exclusive License for Key Intellectual Property Related to Ocular Products

22.01.2010 Genera Biosystems receives TGA approval for its PapType HPV detection and genotyping test

21.01.2010 Expat Centre Leiden officially open

21.01.2010 GATC Biotech Orders Europe’s First HiSeq 2000 for Commercial Use

21.01.2010 Amgen Presents Complete Results From Two Pivotal Phase 3 Studies of Vectibix(R) at Gastrointestinal Cancers Symposium

20.01.2010 Building Biotech Solutions for Diseases of the Developing World

20.01.2010 Ambry Genetics Announces Launch of their StemArray™ Product and Services for High Resolution Characterization of Human Stem Cells

20.01.2010 Oxford BioMedicas UshStat For Usher Syndrome Receives European Orphan Drug Designation

20.01.2010 MorphoSys and WACKER Expand Cooperation to Use WACKER's ESETEC® Technology for Production of Antigen Material

19.01.2010 Jornitz elected Chair of the Board of the global Parental Drug Association

19.01.2010 MorphoSys Enrolls First Patient in Phase 1b/2a Clinical Trial for MOR103 Program in Rheumatoid Arthritis

15.01.2010 FDA Extends Review Period for Tarceva Application for First-line Maintenance Use in Advanced Non-small Cell Lung Cancer

12.01.2010 Kinaxo Extends its Collaboration with Roche

12.01.2010 Protagen AG Appoints New Board Members

12.01.2010 Axis-Shield Granted US Patent for Active-B12 Test

11.01.2010 Amarin Corporation Announces first patients enrolled in Two phase 3 clinical trials Assessing AMR101 for the Treatment of Cardiovascular Disease

08.01.2010 FDA Approves ACTEMRA® (tocilizumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis

08.01.2010 MOLOGEN Successful capital increase completed as planned

06.01.2010 The European cluster Alps Bio Cluster successfully launched its two thematic networks, "Autonomy and Healthcare" and "New Diagnostics and Therapies" thanks to two European-level events.

06.01.2010 Exclusive Distribution Agreement with Response Genetics, Inc.

05.01.2010 Oxford BioMedica Plc Management and Board Changes

I back I top I

office@biotechnology-europe.com I website@biotechnology-europe.com I service@biotechnology-europe.com